LakePharma raises growth capital from Summit Partners and Ampersand Capital Partners
LakePharma, a US biologics company specialising in antibody and protein engineering, cell line development and protein production, has raised USD30 million in growth financing led by global growth equity investor Summit Partners with participation from existing investor Ampersand Capital Partners. The funding will be used to enhance LakePharma’s existing service offering